Literature DB >> 23015366

Muscle relaxant use during intraoperative neurophysiologic monitoring.

Tod B Sloan1.   

Abstract

Neuromuscular blocking agents have generally been avoided during intraoperative neurophysiological monitoring (IOM) where muscle responses to nerve stimulation or transcranial stimulation are monitored. However, a variety of studies and clinical experience indicate partial neuromuscular blockade is compatible with monitoring in some patients. This review presents these experiences after reviewing the currently used agents and the methods used to assess the blockade. A review was conducted of the published literature regarding neuromuscular blockade during IOM. A variety of articles have been published that give insight into the use of partial pharmacological paralysis during monitoring. Responses have been recorded from facial muscles, vocalis muscles, and peripheral nerve muscles from transcranial or neural stimulation with neuromuscular blockade measured in the muscle tested or in the thenar muscles from ulnar nerve stimulation. Preconditioning of the nervous system with tetanic or sensory stimulation has been used. In patients without neuromuscular pathology intraoperative monitoring using peripheral muscle responses from neural stimulation is possible with partial neuromuscular blockade. Monitoring of muscle responses from cranial nerve stimulation may require a higher degree of stimulation and less neuromuscular blockade. The role of tetanic or sensory conditioning of the nervous system is not fully characterized. The impact of neuromuscular pathology or the effect of partial blockade on monitoring muscle responses from spontaneous neural activity or mechanical nerve stimulation has not been described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23015366     DOI: 10.1007/s10877-012-9399-0

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  107 in total

Review 1.  Safety factor at the neuromuscular junction.

Authors:  S J Wood; C R Slater
Journal:  Prog Neurobiol       Date:  2001-07       Impact factor: 11.685

2.  The dose-effect relationship of metocurine: the integrated electromyogram of the first dorsal interosseous muscle and the mechanomyogram of the adductor pollicis compared.

Authors:  A F Kopman
Journal:  Anesthesiology       Date:  1988-04       Impact factor: 7.892

Review 3.  Ion channels and postsynaptic potentials.

Authors:  P W Gage
Journal:  Biophys Chem       Date:  1988-02       Impact factor: 2.352

4.  Ulnar train-of-four stimulation in predicting face movement during intracranial facial nerve stimulation.

Authors:  L C Ho; G Crosby; P Sundaram; S F Ronner; R G Ojemann
Journal:  Anesth Analg       Date:  1989-08       Impact factor: 5.108

5.  Motor cortex stimulation in intact man. 2. Multiple descending volleys.

Authors:  B L Day; J C Rothwell; P D Thompson; J P Dick; J M Cowan; A Berardelli; C D Marsden
Journal:  Brain       Date:  1987-10       Impact factor: 13.501

6.  Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis.

Authors:  F Donati; C Meistelman; B Plaud
Journal:  Anesthesiology       Date:  1991-05       Impact factor: 7.892

7.  Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade.

Authors:  J Viby-Mogensen; P Howardy-Hansen; B Chraemmer-Jørgensen; H Ording; J Engbaek; A Nielsen
Journal:  Anesthesiology       Date:  1981-10       Impact factor: 7.892

8.  Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin.

Authors:  A Spacek; S Nickl; F X Neiger; V Nigrovic; O W Ullrich; M Weindmayr-Goettel; B Schwall; K Taeger; H G Kress
Journal:  Anesthesiology       Date:  1999-06       Impact factor: 7.892

9.  First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.

Authors:  Francois Gijsenbergh; Steven Ramael; Natalie Houwing; Thijs van Iersel
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

10.  Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium.

Authors:  K Leslie; D I Sessler; A R Bjorksten; A Moayeri
Journal:  Anesth Analg       Date:  1995-05       Impact factor: 5.108

View more
  6 in total

1.  Different effects of tetanic stimulation of facial nerve and ulnar nerve on transcranial electrical stimulation motor-evoked potentials.

Authors:  Shen Sun; Fu-Bo Tian; Shao-Qang Huang; Jun Zhang; Wei-Min Liang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 2.  A practical guide for anesthetic management during intraoperative motor evoked potential monitoring.

Authors:  Masahiko Kawaguchi; Hiroki Iida; Satoshi Tanaka; Naokazu Fukuoka; Hironobu Hayashi; Shunsuke Izumi; Kenji Yoshitani; Manabu Kakinohana
Journal:  J Anesth       Date:  2019-10-19       Impact factor: 2.078

3.  Lateral spread response monitoring during microvascular decompression for hemifacial spasm. Comparison of two targets of partial neuromuscular blockade.

Authors:  Y H Chung; W H Kim; J J Lee; S-I Yang; S H Lim; D W Seo; K Park; I S Chung
Journal:  Anaesthesist       Date:  2014-02-07       Impact factor: 1.041

4.  Effects of rocuronium dosage on intraoperative neurophysiological monitoring in patients undergoing spinal surgery.

Authors:  Xueyong Zhang; Hongyu Hu; Ruixu Yan; Tingting Li; Weiwei Wang; Wanchao Yang
Journal:  J Clin Pharm Ther       Date:  2021-11-08       Impact factor: 2.145

Review 5.  Intraoperative Neurophysiological Monitoring for Endoscopic Endonasal Approaches to the Skull Base: A Technical Guide.

Authors:  Harminder Singh; Richard W Vogel; Robert M Lober; Adam T Doan; Craig I Matsumoto; Tyler J Kenning; James J Evans
Journal:  Scientifica (Cairo)       Date:  2016-05-16

6.  Facial Nerve Monitoring under Different Levels of Neuromuscular Blockade with Cisatracurium Besilate in Parotid Tumour Surgery.

Authors:  Huimin Huang; Hong Jiang; Jinxing Liu; Jie Chen; Lin Qiu; Jiayi Wang; Wenhui Liu; Huan Chen
Journal:  Biomed Res Int       Date:  2021-07-13       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.